Harold A. Stein, MD Lecture
COVID-19 and Other Emerging Infectious Diseases: Ophthalmic Manifestations and Their Impact on the Delivery of Eye Care
The Harold A. Stein Lecture will be presented by Gary N. Holland, MD; Professor of Ophthalmology and the Jack H. Skirball Chair in Ocular Inflammatory Diseases in the Department of Ophthalmology, David Geffen School of Medicine at UCLA; and a member of the UCLA Stein Eye Institute. He is Director of the Department of Ophthalmology’s Clinical Research Center, which provides support services for individuals engaged in patient-based research at both the UCLA Stein Eye Institute and the Doheny Eye Institute, and he is Director of the UCLA Stein Eye Institute’s Ocular Inflammatory Disease Center. He has made a substantial commitment to medical student education, teaching and serving on numerous School of Medicine committees.
Dr. Holland will present on the growing SARS-CoV-2 pandemic (and COVID-19, the disease it causes) throughout the world, which has had a profound impact on all aspects of society, including delivery of healthcare. Of particular importance has been implementation of strategies to protect both patients and healthcare providers against virus transmission. Allied health personnel play a critical role in the ability to care for patients safely.
This presentation will provide an update on topics related to the SARS-CoV-2 pandemic that are important for healthcare workers including the latest epidemiologic information; current knowledge about modes of virus transmission; use of personal protective equipment; appropriate modifications to the workplace; and strategies to reduce risk of infection during clinical activities. The potential impact of the pandemic on the future of eye care will be considered. Dr. Holland will also address the infrequent ophthalmic manifestations of SARS-CoV-2 infection, as well as a general overview of vaccine development and treatments for COVID-19.
The presentation will conclude with a discussion of previous epidemics and pandemics of importance to eye care providers, including those involving AIDS, Ebola and Zika, and how those outbreaks have informed our approach to the current SARS-CoV-2 pandemic.
Dr. Holland grew up in southern California where he undertook much of his training. He obtained a Bachelor of Science degree in biological sciences at the University of California, Irvine (1975) and his medical degree at the UCLA School of Medicine, where he also completed residency training in ophthalmology. He undertook fellowship training in both uveitis/external ocular diseases (Francis I. Proctor Foundation, University of California, San Francisco, 1983-1984) and corneal diseases and surgery (Emory University, 1984-1985). He returned to the UCLA Department of Ophthalmology as a faculty member in 1985.
Dr. Holland is particularly interested in infectious diseases of the eye. In 1982, he was the first to describe the ophthalmic manifestations of AIDS. He has continued to be involved in the study of CMV retinitis and other AIDS-related ophthalmic problems. Dr. Holland also has a long-standing interest in ocular toxoplasmosis. He works with investigators in Brazil, Europe and the United States to understand the clinical features of ocular toxoplasmosis more thoroughly and to identify factors related to severity of disease. A third area of clinical and research interest is chronic anterior uveitis in children, as seen in those with juvenile idiopathic arthritis (JIA).
Since 1993, Dr. Holland has served as Associate Editor of the American Journal of Ophthalmology
and is Co-Editor of the textbook, Ocular Infection & Immunity
. He is a Past President of the American Uveitis Society and is a member of both the International Uveitis Study Group (IUSG) and the International Ocular Inflammation Society (IOIS). In 2003, Dr. Holland was chosen to present the LX Edward Jackson Memorial Lecture “Ocular Toxoplasmosis: A Global Reassessment.
” In 2009, he was awarded the Jane Wyman Humanitarian Award by the Arthritis Foundation - Southern California Chapter, for his work on behalf of children with uveitis.
Credits: 1 A IJCAHPO